Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D.

Tseng CW, Masuda C, Chen R, Hartung DM.

Diabetes Care. 2020 Feb 10. pii: dc191294. doi: 10.2337/dc19-1294. [Epub ahead of print] No abstract available.

PMID:
32041898
2.

Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists.

Alley L, Novak K, Havlin T, Irwin AN, Carson J, Johnston K, O'Kane N, Hartung DM.

Res Social Adm Pharm. 2020 Jan 8. pii: S1551-7411(19)30580-7. doi: 10.1016/j.sapharm.2019.12.023. [Epub ahead of print]

PMID:
31953112
3.

Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis.

Hartung DM, Johnston KA, Geddes J, Bourdette DN.

Neurology. 2020 Jan 15. pii: 10.1212/WNL.0000000000008936. doi: 10.1212/WNL.0000000000008936. [Epub ahead of print]

PMID:
31941796
4.

Impact of the RESPOND Toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge.

Irwin AN, Novak K, Alley L, Havlin T, O'Kane N, Johnston K, Hildebran C, Carson J, Hartung DM.

J Am Pharm Assoc (2003). 2020 Jan 6. pii: S1544-3191(19)30538-2. doi: 10.1016/j.japh.2019.11.030. [Epub ahead of print]

PMID:
31919007
5.

Qualitative study on the price of drugs for multiple sclerosis: Gaming the system.

Hartung DM, Alley L, Johnston KA, Bourdette DN.

Neurology. 2020 Jan 28;94(4):e368-e375. doi: 10.1212/WNL.0000000000008653. Epub 2019 Nov 25.

PMID:
31767617
6.

Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Hartung DM, Cohen DM, Deodhar A, Bourdette DN.

Ann Intern Med. 2019 Oct 15;171(8):601-602. doi: 10.7326/L19-0519. No abstract available.

PMID:
31610564
7.

Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.

Bach P, Hartung D.

Addict Sci Clin Pract. 2019 Sep 2;14(1):30. doi: 10.1186/s13722-019-0158-0. Review.

8.

Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis.

Hartung DM, Bourdette D.

JAMA Neurol. 2019 Aug 26. doi: 10.1001/jamaneurol.2019.2445. [Epub ahead of print] No abstract available.

PMID:
31449289
9.

Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.

Rodriguez MI, Hersh A, Anderson LB, Hartung DM, Edelman AB.

Obstet Gynecol. 2019 Jun;133(6):1238-1246. doi: 10.1097/AOG.0000000000003265. Erratum in: Obstet Gynecol. 2019 Jul;134(1):182.

PMID:
31135740
10.

Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.

Anderson L, Hartung DM, Middleton L, Rodriguez MI.

Obstet Gynecol. 2019 Jun;133(6):1231-1237. doi: 10.1097/AOG.0000000000003286.

PMID:
31135739
11.

Repository Corticotropin Versus Glucocorticoid for Nephrotic Syndrome: When Will We See the Evidence?

Hartung DM, Johnston K, Deodhar A, Bourdette DN, Cohen DM.

Am J Kidney Dis. 2019 Aug;74(2):256-262. doi: 10.1053/j.ajkd.2018.12.025. Epub 2019 Feb 11.

PMID:
30765104
12.

Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018.

Hartung DM, Johnston K, Geddes J, Leichtling G, Priest KC, Korthuis PT.

JAMA. 2019 Feb 12;321(6):607-609. doi: 10.1001/jama.2018.20391. No abstract available.

13.

Trends In Coverage For Disease-Modifying Therapies For Multiple Sclerosis In Medicare Part D.

Hartung DM, Johnston KA, Irwin A, Markwardt S, Bourdette DN.

Health Aff (Millwood). 2019 Feb;38(2):303-312. doi: 10.1377/hlthaff.2018.05357.

PMID:
30715973
14.

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.

Hartung DM, Johnston K, Cohen DM, Nguyen T, Deodhar A, Bourdette DN.

JAMA Netw Open. 2018 Jun 1;1(2):e180482. doi: 10.1001/jamanetworkopen.2018.0482.

15.

Variations in prescription drug monitoring program use by prescriber specialty.

Sun BC, Lupulescu-Mann N, Charlesworth CJ, Kim H, Hartung DM, Deyo RA, John McConnell K.

J Subst Abuse Treat. 2018 Nov;94:35-40. doi: 10.1016/j.jsat.2018.08.006. Epub 2018 Aug 17.

16.

Impact of aerobic exercise on muscle mass in patients with major depressive disorder: a randomized controlled trial.

Kerling A, Hartung D, Stubbs B, Kück M, Tegtbur U, Grams L, Weber-Spickschen TS, Kahl KG.

Neuropsychiatr Dis Treat. 2018 Aug 6;14:1969-1974. doi: 10.2147/NDT.S167786. eCollection 2018.

17.

Pharmacists' attitudes, knowledge, utilization, and outcomes involving prescription drug monitoring programs: A brief scoping review.

Johnston K, Alley L, Novak K, Haverly S, Irwin A, Hartung D.

J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):568-576. doi: 10.1016/j.japh.2018.06.003. Epub 2018 Jul 17. Review.

PMID:
30030040
18.

A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations.

Hartung DM, Alley L, Leichtling G, Korthuis PT, Hildebran C.

Addict Behav. 2018 Nov;86:32-39. doi: 10.1016/j.addbeh.2018.04.020. Epub 2018 May 1.

19.

Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.

Getzin T, Gueler F, Hartleben B, Gutberlet M, Thorenz A, Chen R, Meier M, Bräsen JH, Derlin T, Hartung D, Lang HAS, Haller H, Wacker F, Rong S, Hueper K.

Eur Radiol. 2018 Oct;28(10):4455-4464. doi: 10.1007/s00330-018-5380-8. Epub 2018 Apr 30.

PMID:
29713782
20.

Effects of a prior authorization policy for extended-release/long-acting opioids on utilization and outcomes in a state Medicaid program.

Keast SL, Kim H, Deyo RA, Middleton L, McConnell KJ, Zhang K, Ahmed SM, Nesser N, Hartung DM.

Addiction. 2018 Apr 20. doi: 10.1111/add.14248. [Epub ahead of print]

PMID:
29679440
21.

Uses of H.P. Acthar Gel in the Clinical Setting-Reply.

Hartung DM, Bourdette DN, Cohen DM.

JAMA Intern Med. 2018 Apr 1;178(4):583-584. doi: 10.1001/jamainternmed.2017.8545. No abstract available.

PMID:
29610884
22.

18F-FDG PET/CT for Molecular Imaging of Hepatoblastoma in Beckwith-Wiedemann Syndrome.

Derlin T, Hartung D, Hueper K.

Clin Nucl Med. 2018 May;43(5):e164-e165. doi: 10.1097/RLU.0000000000002040.

PMID:
29485435
23.

Elephant in the room.

Hartung DM, Johnston K, Cohen DM, Nguyen T, Deodhar AA, Bourdette DN.

Ann Rheum Dis. 2019 Feb;78(2):e11. doi: 10.1136/annrheumdis-2018-213008. Epub 2018 Jan 23. No abstract available.

PMID:
29363509
24.

T2 Mapping for Noninvasive Assessment of Interstitial Edema in Acute Cardiac Allograft Rejection in a Mouse Model of Heterotopic Heart Transplantation.

Hartung D, Hueper K, Chen R, Gutberlet M, Wacker F, Meier M, Rong S, Jang MS, Bräsen JH, Gueler F.

Invest Radiol. 2018 May;53(5):271-277. doi: 10.1097/RLI.0000000000000438.

PMID:
29261532
25.

Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing.

Sun BC, Charlesworth CJ, Lupulescu-Mann N, Young JI, Kim H, Hartung DM, Deyo RA, McConnell KJ.

Ann Emerg Med. 2018 Mar;71(3):337-347.e6. doi: 10.1016/j.annemergmed.2017.10.023. Epub 2017 Dec 13.

26.

Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?

Sun BC, Lupulescu-Mann N, Charlesworth CJ, Kim H, Hartung DM, Deyo RA, McConnell KJ.

Ann Emerg Med. 2018 Jun;71(6):679-687.e3. doi: 10.1016/j.annemergmed.2017.10.007. Epub 2017 Nov 24.

27.

Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls.

Ruppert J, Hartung D, Westhoff-Bleck M, Herrmann J, Stubbs B, Cordes J, Krüger THC, Lichtinghagen R, Kahl KG.

Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):719-725. doi: 10.1007/s00406-017-0858-y. Epub 2017 Nov 23.

PMID:
29170826
28.

Evaluation of MRI/Ultrasound Fusion-Guided Prostate Biopsy Using Transrectal and Transperineal Approaches.

Tewes S, Peters I, Tiemeyer A, Peperhove M, Hartung D, Pertschy S, Kuczyk MA, Wacker F, Hueper K.

Biomed Res Int. 2017;2017:2176471. doi: 10.1155/2017/2176471. Epub 2017 Sep 28.

29.

68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Extra-adrenal Paraganglioma in a Case of Complete Carney Triad.

Derlin T, Hartung D, Hueper K.

Clin Nucl Med. 2017 Dec;42(12):e527-e528. doi: 10.1097/RLU.0000000000001864.

PMID:
29076898
30.

Pharmacists' Role in Opioid Safety: A Focus Group Investigation.

Hartung DM, Hall J, Haverly SN, Cameron D, Alley L, Hildebran C, O'Kane N, Cohen D.

Pain Med. 2018 Sep 1;19(9):1799-1806. doi: 10.1093/pm/pnx139.

31.

Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes.

Hartung DM, Kim H, Ahmed SM, Middleton L, Keast S, Deyo RA, Zhang K, McConnell KJ.

Subst Abus. 2018;39(2):239-246. doi: 10.1080/08897077.2017.1389798. Epub 2018 May 16.

PMID:
29016245
32.

Trends and Characteristics of US Medicare Spending on Repository Corticotropin.

Hartung DM, Johnston K, Van Leuven S, Deodhar A, Cohen DM, Bourdette DN.

JAMA Intern Med. 2017 Nov 1;177(11):1680-1682. doi: 10.1001/jamainternmed.2017.3631. No abstract available.

33.

Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Hartung DM.

Neurotherapeutics. 2017 Oct;14(4):1018-1026. doi: 10.1007/s13311-017-0566-3. Review.

34.

Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.

Hartung DM, Ahmed SM, Middleton L, Van Otterloo J, Zhang K, Keast S, Kim H, Johnston K, Deyo RA.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1053-1060. doi: 10.1002/pds.4254. Epub 2017 Jul 19.

PMID:
28722211
35.

Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation.

Peperhove M, Vo Chieu VD, Jang MS, Gutberlet M, Hartung D, Tewes S, Warnecke G, Fegbeutel C, Haverich A, Gwinner W, Lehner F, Bräsen JH, Haller H, Wacker F, Gueler F, Hueper K.

Eur Radiol. 2018 Jan;28(1):44-50. doi: 10.1007/s00330-017-4943-4. Epub 2017 Jul 14.

PMID:
28710580
36.

Impact of Hospital "Best Practice" Mandates on Prescription Opioid Dispensing After an Emergency Department Visit.

Sun BC, Lupulescu-Mann N, Charlesworth CJ, Kim H, Hartung DM, Deyo RA, John McConnell K.

Acad Emerg Med. 2017 Aug;24(8):905-913. doi: 10.1111/acem.13230. Epub 2017 Jul 26.

37.

Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation.

Derlin T, Gueler F, Bräsen JH, Schmitz J, Hartung D, Herrmann TR, Ross TL, Wacker F, Wester HJ, Hiss M, Haller H, Bengel FM, Hueper K.

J Nucl Med. 2017 Nov;58(11):1831-1837. doi: 10.2967/jnumed.117.193037. Epub 2017 Apr 27.

38.

Longitudinal evaluation of perfusion changes in acute and chronic renal allograft rejection using arterial spin labeling in translational mouse models.

Hueper K, Schmidbauer M, Thorenz A, Bräsen JH, Gutberlet M, Mengel M, Hartung D, Chen R, Meier M, Haller H, Wacker F, Rong S, Gueler F.

J Magn Reson Imaging. 2017 Dec;46(6):1664-1672. doi: 10.1002/jmri.25713. Epub 2017 Mar 25.

PMID:
28342287
39.

Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains.

Tewes S, Gueler F, Chen R, Gutberlet M, Jang MS, Meier M, Mengel M, Hartung D, Wacker F, Rong S, Hueper K.

PLoS One. 2017 Mar 20;12(3):e0173248. doi: 10.1371/journal.pone.0173248. eCollection 2017.

40.

Interventions to Improve Pharmacological Adherence Among Adults with Psychotic Spectrum Disorders, Bipolar Disorder, and Posttraumatic Stress Disorder [Internet].

Kondo K, Low A, Jindai K, Mendelson A, Motu'apuaka M, Mansoor D, Judge M, Kansagara D, Freeman M, Hartung D.

Washington (DC): Department of Veterans Affairs (US); 2015 Nov.

41.

Interventions to Improve Pharmacological Adherence Among Adults With Psychotic Spectrum Disorders and Bipolar Disorder: A Systematic Review.

Hartung D, Low A, Jindai K, Mansoor D, Judge M, Mendelson A, Kansagara D, Motu Apuaka M, Freeman M, Kondo K.

Psychosomatics. 2017 Mar - Apr;58(2):101-112. doi: 10.1016/j.psym.2016.09.009. Epub 2016 Oct 13. Review.

PMID:
28139249
42.

Reduced muscle mass in middle-aged depressed patients is associated with male gender and chronicity.

Kahl KG, Utanir F, Schweiger U, Krüger TH, Frieling H, Bleich S, Gutberlet M, Hartung D.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:58-64. doi: 10.1016/j.pnpbp.2017.01.009. Epub 2017 Jan 27.

PMID:
28132777
43.

Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2.

Tewes S, Mokov N, Hartung D, Schick V, Peters I, Schedl P, Pertschy S, Wacker F, Voshage G, Hueper K.

PLoS One. 2016 Sep 22;11(9):e0162879. doi: 10.1371/journal.pone.0162879. eCollection 2016.

44.

Multiparametric Functional MRI: Non-Invasive Imaging of Inflammation and Edema Formation after Kidney Transplantation in Mice.

Hueper K, Gutberlet M, Bräsen JH, Jang MS, Thorenz A, Chen R, Hertel B, Barrmeyer A, Schmidbauer M, Meier M, von Vietinghoff S, Khalifa A, Hartung D, Haller H, Wacker F, Rong S, Gueler F.

PLoS One. 2016 Sep 15;11(9):e0162705. doi: 10.1371/journal.pone.0162705. eCollection 2016.

45.

Pericardial adipose tissue and the metabolic syndrome is increased in patients with chronic major depressive disorder compared to acute depression and controls.

Kahl KG, Herrmann J, Stubbs B, Krüger TH, Cordes J, Deuschle M, Schweiger U, Hüper K, Helm S, Birkenstock A, Hartung D.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jan 4;72:30-35. doi: 10.1016/j.pnpbp.2016.08.005. Epub 2016 Aug 13.

PMID:
27528109
46.

Timing of pivotal clinical trial results reporting for newly approved medications varied by reporting source.

Withycombe B, Ovenell M, Meeker A, Ahmed SM, Hartung DM.

J Clin Epidemiol. 2016 Sep;77:78-83. doi: 10.1016/j.jclinepi.2016.04.007. Epub 2016 Apr 22.

PMID:
27108488
47.
48.

Author response.

Hartung DM, Bourdette DN, Ahmed S, Whitham RH.

Neurology. 2015 Nov 10;85(19):1728. No abstract available.

PMID:
26866143
49.

Author response.

Hartung DM, Bourdette DN, Whitham RH.

Neurology. 2015 Nov 10;85(19):1727. No abstract available.

PMID:
26866141
50.

Author response.

Hartung DM, Bourdette DN, Ahmed S, Whitham RH.

Neurology. 2015 Nov 10;85(19):1728. No abstract available.

PMID:
26866072

Supplemental Content

Loading ...
Support Center